91 related articles for article (PubMed ID: 27765510)
1. Synthesis of linear and angular aryl-morpholino-naphth-oxazines, their DNA-PK, PI3K, PDE3A and antiplatelet activity.
Morrison R; Zheng Z; Jennings IG; Thompson PE; Al-Rawi JMA
Bioorg Med Chem Lett; 2016 Nov; 26(22):5534-5538. PubMed ID: 27765510
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 8-aryl-2-morpholino-7-O-substituted benzo[e][1,3]oxazin-4-ones against DNA-PK, PI3K, PDE3A enzymes and platelet aggregation.
Saifuzzaman M; Morrison R; Zheng Z; Orive S; Hamilton J; Thompson PE; Al-Rawi JMA
Bioorg Med Chem; 2017 Oct; 25(20):5531-5536. PubMed ID: 28838830
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione.
Morrison R; Al-Rawi JM
J Enzyme Inhib Med Chem; 2016; 31(sup2):86-95. PubMed ID: 27255290
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines.
Ihmaid S; Al-Rawi J; Bradley C; Angove MJ; Robertson MN; Clark RL
Bioorg Med Chem; 2011 Jul; 19(13):3983-94. PubMed ID: 21664823
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines.
Morrison R; Al-Rawi JM; Jennings IG; Thompson PE; Angove MJ
Eur J Med Chem; 2016 Mar; 110():326-39. PubMed ID: 26854431
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
Pritchard KM; Al-Rawi J; Bradley C
Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural elucidation and DNA-dependant protein kinase and antiplatelet studies of 2-amino-[5, 6, 7, 8-mono and 7, 8-di-substituted]-1,3-benzoxazines.
Ihmaid S; Al-Rawi J; Bradley C
Eur J Med Chem; 2010 Nov; 45(11):4934-46. PubMed ID: 20800933
[TBL] [Abstract][Full Text] [Related]
9. DNA-dependent protein kinase (DNA-PK) inhibitors: structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain.
Clapham KM; Bardos J; Finlay MR; Golding BT; Griffen EJ; Griffin RJ; Hardcastle IR; Menear KA; Ting A; Turner P; Young GL; Cano C
Bioorg Med Chem Lett; 2011 Feb; 21(3):966-70. PubMed ID: 21216595
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents.
Giordanetto F; Barlaam B; Berglund S; Edman K; Karlsson O; Lindberg J; Nylander S; Inghardt T
Bioorg Med Chem Lett; 2014 Aug; 24(16):3936-43. PubMed ID: 25042253
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
Roma G; Di Braccio M; Grossi G; Piras D; Leoncini G; Bruzzese D; Signorello MG; Fossa P; Mosti L
J Med Chem; 2007 Jun; 50(12):2886-95. PubMed ID: 17500510
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
13. Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity.
Abbott BM; Thompson PE
Bioorg Med Chem Lett; 2006 Feb; 16(4):969-73. PubMed ID: 16290931
[TBL] [Abstract][Full Text] [Related]
14. Non-peptide-based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies.
Jaiswal PK; Sharma V; Kumar S; Mathur M; Swami AK; Yadav DK; Chaudhary S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700349. PubMed ID: 29522645
[TBL] [Abstract][Full Text] [Related]
15. Docking and quantitative structure-activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors.
Muñoz-Gutiérrez C; Cáceres-Rojas D; Adasme-Carreño F; Palomo I; Fuentes E; Caballero J
PLoS One; 2017; 12(12):e0189213. PubMed ID: 29216268
[TBL] [Abstract][Full Text] [Related]
16. Design and Development of Novel 4-(4-(1H-Tetrazol-5-yl)-1H-pyrazol-1-yl)-6-morpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine as Cardiotonic Agent via Inhibition of PDE3.
Mao ZW; Li QL; Wang P; Sun YL; Liu Y
Arch Pharm (Weinheim); 2016 Apr; 349(4):268-76. PubMed ID: 26934198
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel 2-amino-3-(naphth-2-yl)propanoic acid derivatives as potent inhibitors of platelet aggregation.
Xie Z; Oscar B; Zhao L; Ding X; Cao C; Feng S; Li H; Pan C; Bian Z; Li Y; Wang W; Kong Y; Li Z
Eur J Med Chem; 2017 Jan; 125():197-209. PubMed ID: 27662032
[TBL] [Abstract][Full Text] [Related]
18. Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives.
Kontogiorgis C; Nicolotti O; Mangiatordi GF; Tognolini M; Karalaki F; Giorgio C; Patsilinakos A; Carotti A; Hadjipavlou-Litina D; Barocelli E
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):925-33. PubMed ID: 25807297
[TBL] [Abstract][Full Text] [Related]
19. Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffold.
Ilić M; Kikelj D; Ilaš J
Eur J Med Chem; 2012 Apr; 50():255-63. PubMed ID: 22365562
[TBL] [Abstract][Full Text] [Related]
20. Pyran derivatives XIX. (Dialkylamino) substituted 1-benzopyranones and naphthopyranones with platelet antiaggregating activity.
Di Braccio M; Roma G; Leoncini G; Poggi M
Farmaco; 1995 Oct; 50(10):703-11. PubMed ID: 8590578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
